Literature DB >> 14228130

DISTRIBUTION OF (2-BROMOETHYL)ETHYL(NAPHTH-1-YMETHYL-(14C))AMINE HYDROBROMIDE IN THE RAT.

J D GRAHAM.   

Abstract

(2-Bromoethyl)ethyl(naphth-1-ylmethyl)amine hydrobromide (SY28) is a halogenoalkylamine related to dibenamine. A dose of 10 mg/kg injected intravenously into rats antagonizes the pressor response to adrenaline for 36 hr. If this amount of SY28 labelled with (14)C in the 1-methyl position is administered, specific radioactivity is present in blood and tissues many days after the antagonism of adrenaline is relieved. The (14)C is excreted in bile and in urine, but not in expired air. It is present in fat but not to a greater extent than it is in other tissues. It does not cross the placental barrier. There is no evidence that slow release from a lipid depot accounts for the long duration of action.

Entities:  

Keywords:  ADIPOSE TISSUE; ANTERIOR CHAMBER; AQUEOUS HUMOR; BRAIN; DIBENAMINE; EPINEPHRINE; EXPERIMENTAL LAB STUDY; HEART; KIDNEY; LIVER; METABOLISM; MUSCLES; NAPHTHALENES; PHARMACOLOGY; RADIOMETRY; RATS; SYMPATHOLYTICS

Mesh:

Substances:

Year:  1964        PMID: 14228130      PMCID: PMC1704092          DOI: 10.1111/j.1476-5381.1964.tb01586.x

Source DB:  PubMed          Journal:  Br J Pharmacol Chemother        ISSN: 0366-0826


  9 in total

1.  Mechanism of the prolonged adrenergic blockade produced by haloalkylamines.

Authors:  M NICKERSON
Journal:  Arch Int Pharmacodyn Ther       Date:  1962-11-01

2.  [Pharmacology and therapeutic uses of the adrenomotor antagonists of the 2-halogenoalkylamines series].

Authors:  J D GRAHAM
Journal:  Recenti Prog Med       Date:  1960-06

3.  Distribution of [14C] bemegride in tissues after intravenous injection.

Authors:  J D GRAHAM; P J NICHOLLS
Journal:  Br J Pharmacol Chemother       Date:  1959-03

4.  [Reversal of the effect of adrenalin on the blood pressure of mice by adrenolytics].

Authors:  G KUSCHINSKY; H VORHERR
Journal:  Arzneimittelforschung       Date:  1958-08

5.  The fate of dibenzyline in the body and the role of fat in its duration of action.

Authors:  B B BRODIE; L ARONOW; J AXELROD
Journal:  J Pharmacol Exp Ther       Date:  1954-05       Impact factor: 4.030

6.  The antihistamine and antiadrenaline properties of a series of N-naphthylmethyl-2-haloethylamine derivatives.

Authors:  J D GRAHAM; G P LEWIS
Journal:  Br J Pharmacol Chemother       Date:  1953-03

7.  The physiological disposition and biotransformation of dibenamine and a method for its estimation in biological tissues.

Authors:  J AXELROD; L ARONOW; B B BRODIE
Journal:  J Pharmacol Exp Ther       Date:  1952-10       Impact factor: 4.030

8.  The ethyleneiminium ion as the active species in 2-haloalkylamine compounds.

Authors:  J D GRAHAM
Journal:  Br J Pharmacol Chemother       Date:  1957-12

9.  The role of the cyclic ethyleneiminium ion in the pharmacological activity of the 2-haloethylamines.

Authors:  J D GRAHAM; G P LEWIS
Journal:  Br J Pharmacol Chemother       Date:  1954-03
  9 in total
  3 in total

1.  Two components of facilitation at the neuromuscular junction of the frog.

Authors:  A Mallart; A R Martin
Journal:  J Physiol       Date:  1967-07       Impact factor: 5.182

2.  Effects of adrenaline on human blood platelets.

Authors:  D C Mills; G C Roberts
Journal:  J Physiol       Date:  1967-11       Impact factor: 5.182

3.  In pursuit of the alpha-adrenoceptor: a fine-structural and electron autoradiographic study using 3H-phenoxybenzamine and smooth muscle from the cat and guinea-pig.

Authors:  J D Graham; C Ivens; J D Lever; R McQuiston; T L Spriggs
Journal:  Br J Pharmacol       Date:  1971-02       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.